Armed with member feedback, the AOA recently issued comments to the Centers for Medicare & Medicaid Services (CMS) on how to improve the EHR Incentive Programs for doctors of optometry.
The AOA has long warned CMS that the meaningful use standards were ill-advised.
Two letters sent to CMS Acting Administrator Andrew M. Slavitt on May 29 and June 15 reflect AOA members' concerns that various regulatory requirements of the EHR Incentive Programs have distracted from the programs' true aim—to increase the number of providers using EHRs to improve patient care.
As stated in the June 15 letter: "Given the serious problems encountered by physicians related to certification and Stage 2 implementation in 2014, program changes are critically needed in 2015 and going forward. The AOA has long warned CMS that the meaningful use standards were ill-advised, placing far too many demands on doctors and software developers."
The AOA parsed CMS' proposed rules on modifications to meaningful use in 2015-2017 as well as the criteria for Stage 3, and offered specific responses to both:
EHR reporting periods
AOA supports a 90-day reporting period in 2015-2016, and also urges CMS continue this into 2017-2018 as the proposal to eliminate the 90-day reporting period in 2017 seems out of step with previous CMS adjustments to the program.
Clinical quality measurement
AOA supports the additional flexibility that CMS has proposed to allow physicians to report on Clinical Quality Measures (CQMs) for any 90-day period in 2015, even if it is different from the 90-day period chosen for attestation for the meaningful use objectives.
Payment adjustments and hardship exemptionsAOA is concerned with the CMS statement that due to the delay in the opening of the attestation period to Jan. 1, 2016, doctors new to the program would experience payment penalties on claims in 2016 that are submitted prior to the doctor’s attestation. AOA suggests it would be preferable to delay implementation of payment penalties until after the attestation period closes.
Patient electronic access
AOA supports the CMS proposal to modify the measure previously requiring 5% of patients to view, download or transmit to third-party health information.
AOA urges finalization of the CMS proposal to modify the secure electronic messaging measure to allow doctors to attest to the capability of EHR for sending and receiving electronic messages, and AOA agrees that CMS should allow for greater flexibility in meeting the patient engagement measures.
Criteria for meaningful use Stage 3
Reporting periodsAOA urges CMS not to eliminate the 90-day reporting period for all physicians—except Medicaid providers in their first year of demonstrating meaningful use—starting in 2017. The number of changes CMS proposed for the next two years make an abbreviated reporting period necessary for doctors trying to meet future program requirements.
Definition of meaningful useAOA strongly opposes the CMS proposal requiring all physicians—regardless of prior participation in the EHR Incentive Programs—to meet Stage 3 requirements by 2019, and AOA encourages more flexibility in allowing doctors in 2017 to remain in Stage 2 or move to Stage 3.
Electronic vs. paper-based objectives and measuresAOA opposes the CMS proposal to discontinue use of non-electronic formats to meet certain measures under Stage 3, namely the use of patient-specific education resources as it seems the use of a certain media type is prioritized over ensuring a patient gets the clinically relevant material they need.
Public health and clinical data reportingAOA is concerned that the public health objectives will be difficult for many physicians to achieve, and AOA encourages CMS to reduce the number of public health or clinical data registry measures required to be reported. AOA urges implementing more exclusions for these measures to allow doctors to exclude measures if their EHR cannot automatically report to these registries.
Virtual AOA on Capitol Hill, May 23-25, is open to all advocacy-minded doctors, optometry students and paraoptometrics. Learn the issues and get involved at optometry’s premier advocacy event.
As AOA advocates in new federal relief legislation and recognition of optometry’s ability to support the U.S. COVID-19 vaccine campaign, Ohio calls on volunteer doctors of optometry to assist.
Despite its name, the National Association of Optometrists and Opticians is a “front” for large optical retailers, working against the interests of doctors of optometry and comprehensive eye health care for patients, the AOA contends in a Jan. 5 letter sent to the Internal Revenue Service. Some companies are now taking steps to disassociate from the lobbying group and its recent actions.